240 related articles for article (PubMed ID: 31352863)
1. Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy.
Zhang W; Ren Y; Li J
Ren Fail; 2019 Nov; 41(1):704-717. PubMed ID: 31352863
[No Abstract] [Full Text] [Related]
2. Improvement of membranous nephropathy by inhibition of miR-193a to affect podocytosis via targeting WT1.
Li J; Chen Y; Shen L; Deng Y
J Cell Biochem; 2019 Mar; 120(3):3438-3446. PubMed ID: 30242881
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of serum miR-106a, miR-19b, miR-17, and PTEN in patients with idiopathic membranous nephropathy.
Wu L; Zhang X; Luo L; Li X; Liu Y; Qin X
J Clin Lab Anal; 2021 Apr; 35(4):e23737. PubMed ID: 33745222
[TBL] [Abstract][Full Text] [Related]
4. Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1.
Li TS; Chen L; Wang SC; Yang YZ; Xu HJ; Gu HM; Zhao XJ; Dong P; Pan Y; Shang ZQ; Zhang XQ; Kong LD
Biochem Pharmacol; 2019 Aug; 166():139-152. PubMed ID: 31085161
[TBL] [Abstract][Full Text] [Related]
5. Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy.
Chen X; Chen Y; Ding X; Zhou Y; Lv Y; Li D; Chen B; Chen T; Chen C
Ren Fail; 2019 Nov; 41(1):363-369. PubMed ID: 31057017
[TBL] [Abstract][Full Text] [Related]
6. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
[TBL] [Abstract][Full Text] [Related]
7. The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy.
Tang Z; Wang Y; Tao L; Guo Y; Zheng Y; Zheng D
BMC Nephrol; 2018 Dec; 19(1):357. PubMed ID: 30541470
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
[TBL] [Abstract][Full Text] [Related]
9. A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia.
Li H; Xing C; Zhou B; Ye H; Feng J; Wu J; Gao S
Exp Hematol; 2018 May; 61():59-68.e5. PubMed ID: 29452230
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
Xie F; Hosany S; Zhong S; Jiang Y; Zhang F; Lin L; Wang X; Gao S; Hu X
PLoS One; 2017; 12(10):e0185565. PubMed ID: 29016617
[TBL] [Abstract][Full Text] [Related]
11. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1.
Gebeshuber CA; Kornauth C; Dong L; Sierig R; Seibler J; Reiss M; Tauber S; Bilban M; Wang S; Kain R; Böhmig GA; Moeller MJ; Gröne HJ; Englert C; Martinez J; Kerjaschki D
Nat Med; 2013 Apr; 19(4):481-7. PubMed ID: 23502960
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression of Urinary Exosomal miRNA in Idiopathic Membranous Nephropathy and Evaluation of its Diagnostic Value.
Guo S; Hao H; Li S; Zhang L; Li R
Tohoku J Exp Med; 2022 Apr; 256(4):327-336. PubMed ID: 35296567
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic Localization of WT1 and Decrease of miRNA-16-1 in Nephrotic Syndrome.
Zapata-Benavides P; Arellano-Rodríguez M; Bollain-Y-Goytia JJ; Franco-Molina MA; Rangel-Ochoa GA; Avalos-Díaz E; Herrera-Esparza R; Rodríguez-Padilla C
Biomed Res Int; 2017; 2017():9531074. PubMed ID: 28299339
[TBL] [Abstract][Full Text] [Related]
14. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.
Chen A; Frank R; Vento S; Crosby V; Chandra M; Gauthier B; Valderrama E; Trachtman H
BMC Nephrol; 2007 Aug; 8():11. PubMed ID: 17683621
[TBL] [Abstract][Full Text] [Related]
16. Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy.
Hong Y; Wang J; Zhang L; Sun W; Xu X; Zhang K
Ann Clin Biochem; 2021 Mar; 58(2):141-148. PubMed ID: 33302703
[TBL] [Abstract][Full Text] [Related]
17. Detection and clinical significance of glomerular M-type phospholipase A
Liu H; Luo W; Gong S; Ding X
Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
[TBL] [Abstract][Full Text] [Related]
18. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
[TBL] [Abstract][Full Text] [Related]
19. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study.
Ham YR; Song CH; Bae HJ; Jeong JY; Yeo MK; Choi DE; Na KR; Lee KW
Dis Markers; 2018; 2018():1463940. PubMed ID: 29682097
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy.
Chen X; Chen Y; Shi K; Lv Y; Tong H; Zhao G; Chen C; Chen B; Li D; Lu Z
Sci Rep; 2017 Sep; 7(1):11468. PubMed ID: 28904360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
